A case of ACTH-independent macronodular adrenal hyperplasia associated with multiple endocrine neoplasia type 1

Endocrine Journal

Volumn 58, Issue 4, 2011, Pages 269-277

  Yoshida, Masanori ^a,b   Hiroi, Maiko ^b   Imai, Tsuneo ^b   Kikumori, Toyone ^b   Himeno, Tatsuhito ^b   Nakamura, Yasuhiro ^c   Sasano, Hironobu ^c   Yamada, Masanobu ^d   Murakami, Yoshiko ^b   Nakamura, Sigeo ^b   Oiso, Yutaka ^b  

^a NAGOYA EKISAIKAI HOSPITAL   (Japan)

^b NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d GUNMA UNIVERSITY   (Japan)

Author keywords

AIMAH; Cushing syndrome; GIP; MEN type 1; MEN1 gene

Indexed keywords

3(OR 17)BETA HYDROXYSTEROID DEHYDROGENASE; CORTICOTROPIN; GASTRIC INHIBITORY POLYPEPTIDE; GLICLAZIDE; STEROID 17ALPHA MONOOXYGENASE;

ADRENAL HYPERPLASIA; ADRENALECTOMY; ADULT; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CORTICOTROPIN BLOOD LEVEL; DEXAMETHASONE SUPPRESSION TEST; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; FEMALE; GENETIC ANALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERCORTISOLISM; HYPERPARATHYROIDISM; HYPOPHYSIS ADENOMA; IMMUNOREACTIVITY; INSULINOMA; MALE; MULTIPLE ENDOCRINE NEOPLASIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS RESECTION; PARATHYROIDECTOMY; PROTEIN EXPRESSION; SEQUENCE ANALYSIS; SOUTHERN BLOTTING;

ADENOMA; ADRENAL HYPERPLASIA, CONGENITAL; ADRENOCORTICOTROPIC HORMONE; ADULT; DEXAMETHASONE; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; PARATHYROID NEOPLASMS; PEDIGREE; RECEPTORS, GASTROINTESTINAL HORMONE;

EID: 79955762336     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.K10E-218     Document Type: Article

References (28)

1. Lacroix A, Bourdeau I (2005) Bilateral adrenal Cushing's syndrome: macronodular adrenal hyperplasia and primary pigmented nodular adrenocortical disease. Endocrinol Metab Clin North Am 34: 441-458.
2. Stratakis CA, Boikos SA (2007) Genetics of adrenal tumors associated with Cushing's syndrome: a new classification for bilateral adrenocortical hyperplasias. Nat Clin Pract Endocrinol Metab 3: 748-757.
3. Findlay JC, Sheeler LR, Engeland WC, Aron DC (1993) Familial adrenocorticotropin-independent Cushing's syndrome with bilateral macronodular adrenal hyperplasia. J Clin Endocrinol Metab 76: 189-191.
4. Miyamura N, Taguchi T, Murata Y, Taketa K, Iwashita S, Matsumoto K, Nishikawa T, Toyonaga T, Sakakida M, Araki E (2002) Inherited adrenocorticotropin-independent macronodular adrenal hyperplasia with abnormal cortisol secretion by vasopressin and catecholamines: detection of the aberrant hormone receptors on adrenal gland. Endocrine 19: 319-326.
5. Lee S, Hwang R, Lee J, Rhee Y, Kim DJ, Chung UI, Lim SK (2005) Ectopic expression of vasopressin V1b and V2 receptors in the adrenal glands of familial ACTH-independent macronodular adrenal hyperplasia. Clin Endocrinol (Oxf) 63: 625-630.
6. Vezzosi D, Cartier D, Régnier C, Otal P, Bennet A, Parmentier F, Plantavid M, Lacroix A, Lefebvre H, Caron P (2007) Familial adrenocorticotropin-independent macronodular adrenal hyperplasia with aber rant serotonin and vasopressin adrenal receptors. Eur J Endocrinol 156: 21-31.
7. Lemos MC, Thakker RV (2008) Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene. Hum Mutat 29: 22-32.
8. Skogseid B, Larsson C, Lindgren PG, Kvanta E, Rastad J, Theodorsson E, Wide L, Wilander E, Oberg K (1992) Clinical and genetic features of adrenocortical lesions in multiple endocrine neoplasia type 1. J Clin Endocrinol Metab 75: 76-81.
9. Burgess JR, Harle RA, Tucker P, Parameswaran V, Davies P, Greenaway TM, Shepherd JJ (1996) Adrenal lesions in a large kindred with multiple endocrine neoplasia type 1. Arch Surg 131: 699-702.
10. Langer P, Cupisti K, Bartsch DK, Nies C, Goretzki PE, Rothmund M, Röher HD (2002) Adrenal involvement in multiple endocrine neoplasia type 1. World J Surg 26: 891-896.
11. Waldmann J, Bartsch DK, Kann PH, Fendrich V, Rothmund M, Langer P (2007) Adrenal involvement in multiple endocrine neoplasia type 1: results of 7 years prospective screening. Langenbecks Arch Surg 392: 437-443.
12. Whitley SA, Moyes VJ, Park KM, Brooke AM, Grossman AB, Chew SL, Rockall AG, Monson JP, Reznek RH (2008) The appearance of the adrenal glands on computed tomography in multiple endocrine neoplasia type 1. Eur J Endocrinol 159: 819-824.
13. Barzon L, Pasquali C, Grigoletto C, Pedrazzoli S, Boscaro M, Fallo F (2001) Multiple endocrine neoplasia type 1 and adrenal lesions. J Urol 166: 24-27.
14. Sasano H, Suzuki T, Nagura H (1994) ACTHindependent macronodular adrenocortical hyperplasia: immunohistochemical and in situ hybridization studies of steroidogenic enzymes. Mod Pathol 7: 215-219.
15. Uchino S, Noguchi S, Sato M, Yamashita H, Yamashita H, Watanabe S, Murakami T, Toda M, Ohshima A, Futata T, Mizukoshi T, Koike E, Takatsu K, Terao K, Wakiya S, Nagatomo M, Adachi M (2000) Screening of the Men1 gene and discovery of germ-line and somatic mutations in apparently sporadic parathyroid tumors. Cancer Res 60: 5553-5557.
16. Wright RJ, Frier BM (2008) Vascular disease and diabetes: is hypoglycaemia an aggravating factor? Diabetes Metab Res Rev 24: 353-363.
17. Owens M, Ellard S, Vaidya B (2008) Analysis of gross deletions in the MEN1 gene in patients with multiple endocrine neoplasia type 1. Clin Endocrinol (Oxf) 68: 350-354.
18. Georgitsi M, Raitila A, Karhu A, van der Luijt RB, Aalfs CM, Sane T, Vierimaa O, Mäkinen MJ, Tuppurainen K, Paschke R, Gimm O, Koch CA, Gündogdu S, Lucassen A, Tischkowitz M, Izatt L, Aylwin S, Bano G, Hodgson S, De Menis E, Launonen V, Vahteristo P, Aaltonen LA (2007) Germline CDKN1B/p27Kip1 mutation in multiple endocrine neoplasia. J Clin Endocrinol Metab 92: 3321-3325.
19. Agarwal SK, Mateo CM, Marx SJ (2009) Rare germline mutations in cyclin-dependent kinase inhibitor genes in multiple endocrine neoplasia type 1 and related states. J Clin Endocrinol Metab 94: 1826-1834.
20. Doppman JL, Chrousos GP, Papanicolaou DA, Stratakis CA, Alexander HR, Nieman LK (2000) Adrenocorticotropin-independent macronodular adrenal hyperplasia: an uncommon cause of primary adrenal hypercortisolism. Radiology 216: 797-802.
21. Gicquel C, Leblond-Francillard M, Bertagna X, Louvel A, Chapuis Y, Luton JP, Girard F, Le Bouc Y (1994) Clonal analysis of human adrenocortical carcinomas and secreting adenomas. Clin Endocrinol (Oxf) 40: 465-477.
22. Bourdeau I, Antonini SR, Lacroix A, Kirschner LS, Matyakhina L, Lorang D, Libutti SK, Stratakis CA (2004) Gene array analysis of macronodular adrenal hyperplasia confirms clinical heterogeneity and identifies several candidate genes as molecular mediators. Oncogene 23: 1575-1585.
23. Groussin L, Perlemoine K, Contesse V, Lefebvre H, Tabarin A, Thieblot P, Schlienger JL, Luton JP, Bertagna X, Bertherat J (2002) The ectopic expression of the gastric inhibitory polypeptide receptor is frequent in adrenocorticotropin-independent bilateral macronodular adrenal hyperplasia, but rare in unilateral tumors. J Clin Endocrinol Metab 87: 1980-1985.
24. Nawata H, Demura H, Suda T, Takayanagi R (1995) Preclinical Cushing syndrome (1996) Preclinical Cushing syndrome, Annual report of the Ministry of Health and Welfare "disorder of adrenal hormones" research committee, Tokyo, Japan 223-226 (In Japanese).
25. Katabami T, Obi R, Shirai N, Naito S, Saito N (2005) Discrepancies in results of low-and high-dose dexamethasone suppression tests for diagnosing preclinical Cushing's syndrome. Endocr J 52: 463-469.
26. Stratakis CA, Sarlis N, Kirschner LS, Carney JA, Doppman JL, Nieman LK, Chrousos GP, Papanicolaou DA (1999) Paradoxical response to dexamethasone in the diagnosis of primary pigmented nodular adrenocortical disease. Ann Intern Med 131: 585-591.
27. Molatore S, Pellegata NS (2010) The MENX syndrome and p27: relationships with multiple endocrine neoplasia. Prog Brain Res 182: 295-320.
28. Lampron A, Bourdeau I, Hamet P, Tremblay J, Lacroix A (2006) Whole genome expression profiling of glucose-dependent insulinotropic peptide (GIP)-and adrenocorticotropin-dependent adrenal hyperplasias reveals novel targets for the study of GIP-dependent Cushing's syndrome. J Clin Endocrinol Metab 91: 3611-3618.